Alvotech (ALVO) Divestments (2024 - 2025)
Alvotech's (ALVO) quarterly Divestments came in at $9.0 million in Q3 2025, up 403.87% YoY from $1.8 million in Q3 2024, and up 203.36% on a QoQ basis from $3.0 million in Q1 2025.
Alvotech (ALVO) Divestments (2024 - 2025) Analysis & Trends
Alvotech (ALVO) has 2 years of Divestments data on file, last reported at $9.0 million in Q3 2025.
- Quarterly Divestments rose 403.87% year-over-year to $9.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $24.0 million (changed N/A YoY) and the FY2020 annual result came in at -$5.0 million, changed 0.0% from the prior year.
- Divestments climbed to $9.0 million in Q3 2025, from $3.0 million in the prior quarter.
- In the past five years, Divestments ranged from a high of $12.0 million in Q4 2024 to a low of -$3.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 65.64 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.03 Mn |
| Mar 31, 2025 | 2.98 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Sep 30, 2024 | -2.97 Mn |